Delhi’s MAMC Launches Dedicated Medical Genetics Department, Marking Major Push for Precision Medicine in Public Sector

Spread the Message

Read Time:7 Minute, 36 Second

New Delhi’s Maulana Azad Medical College (MAMC) and its associated Lok Nayak Hospital have inaugurated a dedicated Department of Medical Genetics, a move positioned as a major step towards bringing advanced, gene-based diagnostics and therapies into the government healthcare system of the national capital. The department—formally approved by the University of Delhi and inaugurated by Delhi Chief Minister Rekha Gupta on Friday—will address genetic disorders across the entire life span, with a special focus on children and rare diseases.

What the new department will do

According to official statements, the Department of Medical Genetics will focus on diagnosing and managing genetic disorders from the fetal and newborn stages through adulthood and old age. Its remit includes common congenital conditions as well as rare, inherited and late-onset genetic diseases that often go undetected or are diagnosed late in resource-limited settings.

Officials have indicated that the department will offer:

Advanced genetic diagnostics, including molecular and cytogenetic tests, for suspected genetic conditions across age groups.
Early risk prediction for families with known hereditary disorders, enabling preconception, prenatal and newborn screening where appropriate.
Access to emerging treatments such as gene therapy, antisense oligonucleotide therapy and select in‑utero interventions, as and when feasible within the public system.

The department is expected to integrate closely with services such as fetal medicine, pediatrics, internal medicine and oncology, reflecting the reality that genetics cuts across virtually every medical specialty.

Why genetics services matter in India

India carries a substantial burden of genetic disorders, driven by its large population, high birth rate and, in some communities, consanguineous marriages. A landmark analysis estimated that each year the country sees around 495,000 infants with congenital malformations, 390,000 with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency, 21,400 with Down syndrome, 9,000 with beta‑thalassemia, 5,200 with sickle cell disease and nearly 9,760 with amino acid disorders. Many of these conditions require specialized diagnostic facilities, long-term follow‑up and multidisciplinary care.

Despite this burden, comprehensive genetic services have historically been limited to a few tertiary centers, often in the private sector or in select government teaching hospitals. Lok Nayak Hospital already hosts a genetic laboratory and clinic that has been providing specialized diagnostics, counseling and management for more than 13 years, and is recognized as a Centre of Excellence for rare diseases by the Ministry of Health and Family Welfare. Elevating these services into a full-fledged Department of Medical Genetics formalizes and expands their role in patient care, training and research.

“This development is important because genetic diseases are no longer rare curiosities—they are a significant contributor to infant mortality, childhood disability and even adult chronic disease,” said Dr. Ananya Rao, a clinical geneticist at a separate government teaching hospital in North India, who is not involved with MAMC. “Having a dedicated department in a major public hospital increases the likelihood that patients from diverse socioeconomic backgrounds can access timely diagnosis and counseling.”

Link to precision oncology and advanced therapies

The new department is also expected to be a key partner in advancing cancer genetics and precision oncology within the public sector. Genetic profiling of tumors and inherited cancer risk genes is increasingly used to guide prognosis, tailor chemotherapy and targeted drugs, and identify individuals who may benefit from enhanced surveillance.

Precision oncology uses detailed information about a patient’s tumor—such as specific gene mutations, RNA signatures and protein markers—to select treatments that are more likely to work and less likely to cause unnecessary side effects. Indian cancer centers in the private sector, including major hospitals in Mumbai and Bengaluru, already offer molecular tumor profiling and personalized treatment plans as part of their oncology services. Bringing similar capabilities into a government institution can help reduce the gap between public and private care.

Delhi Health Minister Pankaj Kumar Singh described the initiative as a move towards “precision and preventive medicine” in the public sector, highlighting the combination of advanced diagnostics, gene-based therapies and specialized training. “Genetic science will help us detect diseases early and treat them better,” he said, emphasizing the goal of delivering “world-class, technology-driven healthcare” through public hospitals.

Training the next generation of specialists

As part of the approval, the University of Delhi has sanctioned two super‑specialty seats in Medical Genetics at MAMC, typically equivalent to DM (Doctorate of Medicine) training positions. These seats are expected to strengthen clinical genetics, precision medicine and rare disease care by creating a structured pathway for advanced training within the public system.

India’s need for more trained geneticists has been highlighted repeatedly in academic literature. Many practicing physicians rely primarily on limited genetics teaching from their undergraduate years, and medical genetics is often taught in a fragmented manner across multiple departments. “If we want genetic services to become part of routine care—in obstetrics, pediatrics, oncology, cardiology and neurology—we need more clinicians who can interpret tests, counsel families and coordinate care,” noted Dr. Rao. “Dedicated DM programs in Medical Genetics are crucial to building that workforce.”

By formalizing training, MAMC and Lok Nayak Hospital join a small but growing group of government medical institutions offering advanced genetics education alongside tertiary and quaternary-level clinical services.

Implications for patients and families

For patients, the presence of a dedicated medical genetics department can influence care in several practical ways:

Earlier diagnosis: Children with developmental delay, birth defects or unexplained seizures may get a faster, more accurate diagnosis through targeted genetic testing, potentially avoiding years of uncertainty and unnecessary investigations.
Informed reproductive choices: Couples with a history of genetic disorders such as thalassemia or certain neuromuscular conditions can receive counseling and, where appropriate, options such as carrier testing and prenatal diagnosis.
Risk-based screening: Individuals with strong family histories of cancers or cardiac conditions may be offered genetic assessment and recommended tailored screening strategies.

For example, a couple whose first child has beta‑thalassemia major may be advised to undergo carrier testing and, in a future pregnancy, consider prenatal diagnostic options if both are found to be carriers. Such interventions can help families make informed decisions while also contributing to longer‑term public health strategies for conditions like thalassemia and sickle cell disease.

However, experts stress that genetics should complement, not replace, core public health measures. “Genetic testing is powerful, but it must be integrated with counseling, ethical safeguards and equitable access,” Dr. Rao said. “Otherwise, we risk creating a system where only a small subset of patients benefits from these advances.”

Challenges, ethics and limitations

While the launch of the department is widely seen as a positive step, several challenges remain. Access to advanced molecular tests and gene therapies can be constrained by cost, laboratory capacity and the need for robust quality control systems. In many cases, gene-based treatments are still emerging, and their long-term safety, effectiveness and affordability in low‑ and middle‑income settings require further study.

Ethical considerations are also central to expanding genetic services. These include:

Ensuring informed consent and clear communication about what tests can and cannot reveal.
Safeguarding privacy and preventing discrimination based on genetic information.
Providing adequate psychological support for individuals and families receiving complex or difficult diagnoses.

Moreover, the existing burden of genetic disorders in India is likely under‑estimated due to under‑diagnosis and lack of systematic surveillance, which means the new department may face high demand from the outset. Strengthening referral pathways from primary and secondary care, investing in laboratory infrastructure and training allied health professionals such as genetic counselors will be essential to ensure that services are both effective and sustainable.

What this means for readers

For health‑conscious readers and families, the establishment of a Department of Medical Genetics at a major government teaching hospital signals a broader shift in Indian healthcare towards more personalized, evidence‑based care. While not every individual will need genetic testing, those with a personal or family history of inherited disorders, recurrent pregnancy losses, birth defects or certain cancers may benefit from discussing genetics with their treating doctors.

Practical steps include:

Asking your healthcare provider whether a genetic evaluation is appropriate in cases of unexplained developmental delay, multiple affected family members or early‑onset serious diseases.
Seeking care at recognized centers, such as those designated as Centers of Excellence for rare diseases, when complex genetic conditions are suspected.
Understanding that genetic tests should be accompanied by professional counseling to interpret results and guide next steps.

As departments like the one at MAMC expand and mature, they have the potential not only to improve individual patient outcomes but also to inform public health policies on screening, prevention and long‑term care for genetic disorders across India.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.